Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Hot AXIOS™ for Bile Duct Drainage in Malignant Stenosis

Not Applicable

Recruiting

Conditions: Malignant Biliary Stenosis

First Posted Date: 2024-12-27

Last Posted Date: 2025-06-24

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 162

Registration Number: NCT06750146

Locations: 🇫🇷
CHU de Besançon, Besançon, France
🇫🇷
Clinique des Cedres, Ramsay Sante, Cornebarrieu, France
🇫🇷
CHU Limoges, Limoges, France

and more 15 locations

Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System

Not Applicable

Recruiting

Conditions: Persistent Atrial Fibrillation

First Posted Date: 2024-12-16

Last Posted Date: 2025-06-25

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 407

Registration Number: NCT06735534

Locations: 🇺🇸
Arrhythmia Research Group-Research Facility, Jonesboro, Arkansas, United States

cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia

Recruiting

Conditions: Concomitant Procedures
Atrial Fibrillation
PFA
LAAC

First Posted Date: 2024-11-13

Last Posted Date: 2025-06-04

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 433

Registration Number: NCT06686485

Locations: 🇨🇳
Beijing Anzhen Hospital of the Capital University of Medical Sciences, Beijing, China
🇲🇾
Institute Jantung Negara, Kuala Lumpur, Malaysia

RIVOS Feasibility (MBO)

Not Applicable

Not yet recruiting

Conditions: Malignant Biliary Obstruction

First Posted Date: 2024-10-31

Last Posted Date: 2025-06-12

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 20

Registration Number: NCT06666699

Locations: 🇧🇪
Ghent University Hospital, Ghent, Belgium
🇫🇷
Georges Pompidou European Hospital, Paris, France
🇮🇳
Asian Institute of Gastroenterology, Hyderabad, Telangana, India

FARAPULSE Workflow Assessment Registry

Recruiting

Conditions: Atrial Fibrillation (AF)

First Posted Date: 2024-10-24

Last Posted Date: 2025-06-20

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 500

Registration Number: NCT06656884

Locations: 🇩🇪
Munchen Klinik Bogenhausen, München, Germany
🇦🇹
A.o. Krankenhaus der Elisabethinen Linz, Linz, Austria
🇧🇪
Ziekenhuis aan de Stroom, Middelheim, Antwerp, Belgium

and more 30 locations

A Prospective, Multi-center Study to Evaluate Efficacy and Safety of BSJ020R in Treatment of AVF for Hemodialysis (RANGER AV Japan Study)

Not Applicable

Recruiting

Conditions: Arteriovenous Fistula Stenosis
Arteriovenous Fistula
Vascular Access

First Posted Date: 2024-10-15

Last Posted Date: 2025-06-12

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 186

Registration Number: NCT06639451

Locations: 🇯🇵
Kansai Rosai Hospital, Amagasaki, Hyogo, Japan
🇯🇵
Yokohama Dai-ichi Hospital, Yokohama, Kanagawa, Japan
🇯🇵
Kishiwada Tokushukai Hospital, Kishiwada, Osaka, Japan

and more 5 locations

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Recruiting

Conditions: Movement Disorders
Parkinson Disease
Dystonia
Essential Tremor

Interventions: Device: Radiofrequency Ablation

First Posted Date: 2024-08-14

Last Posted Date: 2025-06-08

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 200

Registration Number: NCT06553625

Locations: 🇩🇪
Uniklinik Köln, Cologne, Germany
🇩🇪
Universitaetsklinikum Dusseldorf, Dusseldorf, Germany
🇬🇧
St. Georges Hospital, London, United Kingdom

ADVENT Trial Long Term Outcomes Evaluating Atrial Fibrillation Progression Study

Conditions: Paroxysmal Atrial Fibrillation

First Posted Date: 2024-07-30

Last Posted Date: 2025-06-29

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 583

Registration Number: NCT06526546

Locations: 🇺🇸
Medical University of South Carolina, Charleston, South Carolina, United States
🇺🇸
Grandview Medical Center, Birmingham, Alabama, United States
🇺🇸
Banner University Medical Center Phoenix, Phoenix, Arizona, United States

and more 23 locations

SIMPLAAFY Clinical Trial

Not Applicable

Recruiting

Conditions: Stroke
Bleeding
Atrial Fibrillation

Interventions: Device: WATCHMAN FLX Pro LAAC Device

First Posted Date: 2024-07-26

Last Posted Date: 2025-06-17

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 1857

Registration Number: NCT06521463

Locations: 🇺🇸
University of Alabama Birmingham, Birmingham, Alabama, United States
🇺🇸
Grandview Medical Center, Birmingham, Alabama, United States
🇺🇸
Phoenix Cardiovascular Research Group, Phoenix, Arizona, United States

and more 69 locations

Feasibility Study of the FARAFLEX Mapping and PFA System

Not Applicable

Recruiting

Conditions: Atrial Fibrillation
Persistent Atrial Fibrillation

Interventions: Device: Ablation Treatment

First Posted Date: 2024-07-19

Last Posted Date: 2025-06-06

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 100

Registration Number: NCT06510556

Locations: 🇨🇿
Nemocnice Na Homolce Hospital, Prag, Czechia
🇭🇷
Klinicki bolnicki centar Split, Split, Croatia

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy